Company intelligence / Profile preview
Scandinavian Biopharma
Solna, Stockholm, Sweden
- Ownership
- Private
- Employees
- ~35
- Development stage
- Phase 3
01
Overview
Successfully completed a large pediatric Phase IIb trial for ETVAX® vaccine against ETEC in The Gambia. Planning for Phase III trials for their ETEC vaccine for both children in low- and middle-income countries and travelers
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- VaccinesImmunoglobulins
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
VaxAlta Inc.University of GothenburgPATHUSAMMDANeovii Pharmaceuticals AGAJ VaccinesKedrionFlynn PharmaEmergent BiosolutionsTravel Health Group
Beyond the preview
Go deeper on Scandinavian Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scandinavian Biopharma.